UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 603

Sortiert nach

Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility

Chemical communications (Cambridge, England), 2014-01, Vol.50 (14), p.1688-1690

2014

Volltextzugriff (PDF)

Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo

European journal of pharmaceutical sciences, 2012-02, Vol.45 (3), p.336-343

2012

Volltextzugriff (PDF)

Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development

Pharmaceutical research, 2012-06, Vol.29 (6), p.1485-1494

2012

Volltextzugriff (PDF)

Solution or suspension – Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug

European journal of pharmaceutics and biopharmaceutics, 2017-08, Vol.117, p.308-314

2017

Volltextzugriff (PDF)

Increasing the proportional content of surfactant (cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs

Pharmaceutical research, 2007-04, Vol.24 (4), p.748-757

2007

Volltextzugriff (PDF)

Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation

Pharmaceutical research, 2004-08, Vol.21 (8), p.1405-1412

2004

Volltextzugriff (PDF)

Miniaturized ionic liquid dispersive liquid–liquid microextraction in a coupled-syringe system combined with UV for extraction and determination of danazol in danazol capsule and mice serum

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2016-04, Vol.159, p.163-168

2016

Volltextzugriff (PDF)

Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug

European journal of pharmaceutical sciences, 2005-03, Vol.24 (4), p.297-303

2005

Volltextzugriff (PDF)

LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy

Therapeutic drug monitoring, 2014-12, Vol.36 (6), p.828

2014

Volltextzugriff (PDF)

Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device

Fertility and sterility, 2000-08, Vol.74 (2), p.412-413

2000

Volltextzugriff (PDF)

Voltammetric study of danazol and its determination in capsules and spiked biological fluids

Journal of pharmaceutical and biomedical analysis, 2005-02, Vol.37 (1), p.199-204

2005

Volltextzugriff (PDF)

Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single- and Double-Peak Phenomena in the Plasma Profiles

Journal of clinical pharmacology, 1993-12, Vol.33 (12), p.1207-1213

1993

Volltextzugriff (PDF)

Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations : relationship to AUC from zero to time infinity (AUC0-INF)

Pharmaceutical research, 1991-04, Vol.8 (4), p.512-517

1991

Volltextzugriff (PDF)

Levels of androgens and danazol metabolites in serum during danazol therapy

Fertility and sterility, 1993-07, Vol.60 (1), p.179-181

1993

Volltextzugriff (PDF)

Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans

Biopharmaceutics & drug disposition, 1991-11, Vol.12 (8), p.577-582

1991

Volltextzugriff (PDF)

A liquid chromatographic method for the determination of danazol in human serum

Journal of pharmaceutical and biomedical analysis, 1990, Vol.8 (1), p.79-84

1990

Volltextzugriff (PDF)

Carbamazepine-danazol drug interaction: its mechanism examined by a stable isotope technique

Therapeutic drug monitoring, 1986-01, Vol.8 (4), p.387-392

1986

Volltextzugriff (PDF)

Radioimmunoassay for Danazol in Human and Monkey Plasma

Journal of pharmaceutical sciences, 1978-10, Vol.67 (10), p.1425-1428

1978

Volltextzugriff (PDF)

No inhibitory effects of danazol estrogen production by ovaries of hypophysectomized rats stimulated by gonadotropins

In vivo (Athens), 1993-03, Vol.7 (2), p.127

1993

Volltextzugriff (PDF)

Danazol concentrations in human ovarian follicular fluid and their relationship to simultaneous serum concentrations

Fertility and sterility, 1988-01, Vol.49 (1), p.42-46

1988

Volltextzugriff (PDF)

Further studies on danazol interference in testosterone radioimmunoassays

Clinical chemistry (Baltimore, Md.), 1983-01, Vol.29 (1), p.141

1983

Volltextzugriff (PDF)

Pharmacology and pharmacokinetics of danazol

Drugs (New York, N.Y.), 1980-05, Vol.19 (5), p.321-330

1980

Volltextzugriff (PDF)

Analysis of danazol and its metabolites in serum by RP-HPLC with maxplot UV detector

Yao hsüeh hsüeh pao, 1988, Vol.23 (9), p.698

1988

Volltextzugriff (PDF)

Solid-phase chemiluminescence immunoassay for progesterone in unextracted serum

Clinical chemistry (Baltimore, Md.), 1984-10, Vol.30 (10), p.1637

1984

Volltextzugriff (PDF)

Inhibition of Adrenal Steroidogenesis by Danazol in Vivo

Fertility and sterility, 1980-04, Vol.33 (4), p.401-406

1980

Volltextzugriff (PDF)

1 – 25 von 603

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(511)
Mit Volltextzugriff
(360)

Publikationsform

Artikel
(602)
magazinearticle
(1)

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility

Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo

Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development

Solution or suspension – Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug

Increasing the proportional content of surfactant (cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs

Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation

Miniaturized ionic liquid dispersive liquid–liquid microextraction in a coupled-syringe system combined with UV for extraction and determination of danazol in danazol capsule and mice serum

Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug

LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy

Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device

Voltammetric study of danazol and its determination in capsules and spiked biological fluids

Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single- and Double-Peak Phenomena in the Plasma Profiles

Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations : relationship to AUC from zero to time infinity (AUC0-INF)

Levels of androgens and danazol metabolites in serum during danazol therapy

Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans

A liquid chromatographic method for the determination of danazol in human serum

Carbamazepine-danazol drug interaction: its mechanism examined by a stable isotope technique

Radioimmunoassay for Danazol in Human and Monkey Plasma

No inhibitory effects of danazol estrogen production by ovaries of hypophysectomized rats stimulated by gonadotropins

Danazol concentrations in human ovarian follicular fluid and their relationship to simultaneous serum concentrations

Further studies on danazol interference in testosterone radioimmunoassays

Pharmacology and pharmacokinetics of danazol

Analysis of danazol and its metabolites in serum by RP-HPLC with maxplot UV detector

Solid-phase chemiluminescence immunoassay for progesterone in unextracted serum

Inhibition of Adrenal Steroidogenesis by Danazol in Vivo

Suchergebnisse filtern